 Favorites |
 Google |
 Digg |
 Del.icio.us |
 Twitter |
 Facebook |
>> More...
A Shot Against MRSA?
A briefing on the challenges around developing a staph vaccine.
Published: April 23, 2009
Get full text or downloads
Every year in the United States, 2 million people become infected with Staphylococcus aureus bacteria, or "staph," and 100,000 of them die. Skin infections are the most common, but staph infections of the lung (pneumonia) and bloodstream (bacteremia) are the deadliest.
A staph vaccine would save lives and money, reduce the use of antibiotics, and slow the spread of antibiotic resistance. That is, if a vaccine is targeted to people when their risk of becoming infected with staph is highest—when they go to the hospital for surgery or some other invasive procedure. That’s because the science suggests that even the most successful vaccine will provide immunity for just a limited time. But we are still far from being able to vaccinate against staph.
This policy brief from Extending the Cure examines the obstacles around developing a staph vaccine.
Share:
Recommended
- Which MRSA is It? Community-Acquired MRSA versus Hospital-Acquired MRSA (Issue and policy briefs)
- Antibiotic Resistance: A Growing Threat (Stories and articles)
- Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance (Reports)
Related Web sites
Which MRSA is It? Community-Acquired MRSA versus Hospital-Acquired MRSA
Publication date:
March 2008
Summary:
A policy brief from RWJF grantee Extending the Cure discusses the responses to community-acquired MRSA (methicillin-resistant Staphylococcus aureus).
Antibiotic Resistance: A Growing Threat
Publication date:
November 20, 2007
Summary:
Extending the Cure presents a series of policy briefs setting the stage for future action and continued research to prevent widespread antibiotic resistance.
Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance
By:
Laxminarayan R and Malani A
Publication date:
March 22, 2007
Summary:
In this report, the authors examine the problem of antibiotic resistance from a natural resources perspective and propose solutions from an incentive-based perspective.
The Pioneer Portfolio has launched Pioneering Ideas, a blog for RWJF staff, grantees and other innovators to share breakthrough ideas for health and health care. Here are several recent entries: